Evaluating Perioperative Outcomes: Dexmedetomidine vs Lignocaine in Laparoscopic Chlolecystectomy

NCT06740903 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

140

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hemodynamics Instability
Post Operative Pain
Gastrointestinal Dysfunction
Cholecystitis

Interventions

DRUG: inj. dexmedetomidine infusion @ 0.2-0.4 μg/kg/h
DRUG: inj. lignocaine infusion @1-2 mg/kg/h

Sponsor

Sahiwal medical college sahiwal

Collaborators

[object Object]